Similarly, we hypothesized that MEDI6383 would protect conventional CD4 T cells from Treg-mediated suppression as has been reported for other OX40 agonists

Similarly, we hypothesized that MEDI6383 would protect conventional CD4 T cells from Treg-mediated suppression as has been reported for other

Continue readingSimilarly, we hypothesized that MEDI6383 would protect conventional CD4 T cells from Treg-mediated suppression as has been reported for other OX40 agonists